AsthmaAA2000NCT04727112
Asthma and Allergy Screening AA2000 (Cross Sectional)
An observational study of Asthma, run by Bispebjerg Hospital.
Trial summary
Asthma screening of 493 asthma patients Read more about this study
- Who is it for?
- Ages 15 to 45 years
- Conditions the study is for
- Asthma
- How many people
- 493 participants
- Where
- No sites listed yet
- Study dates
- Jan 2000to Jan 2004
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 45 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Population based asthma study
Who may be able to join
None listed.
Who cannot join
- -
About this study
Asthma screening of 493 asthma patients
Read the detailed description
Questionnaire, and testing
- Conditions
- Asthma
- Being tested
- Usual care versus primary care
- Keywords
- asthma, airway hyperresponsiveness, asthma management
- Medical subject headings
- Asthma, Respiratory Hypersensitivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Usual care versus primary careDrug
Also called RCT study, usuar care in specialist setting (GINA and ARIA)
RCT study
| Study group | Role | What they receive |
|---|---|---|
| asthma and rhinitis | Screening of patients with upper and lower airway symptoms Receives: Drug: Usual care versus primary care | |
| asthma and rhintis follow-up | same Group as screened in 2000, was followed up three years later Receives: Drug: Usual care versus primary care |
What is being measured
The primary outcome is the main question the study is designed to answer.
ACQ
Questionnaire based
Measured: 2004
AQLQ
Questionnaire based
Measured: 2004
Secondary outcomes (1)
FEV1
Lung function
Measured: 2004
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jan 2021
- Study startJan 2000
- Primary completionJan 2003
- Study completionJan 2004
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 493 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bispebjerg Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Vibeke Backer, Bispebjerg Hospital
- Investigators
- Vibeke Backer, MD, Principal investigator, Bispebjerg Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04727112
- Sponsor's protocol ID
- asthma and allergy screening
- Acronym
- AA2000
- Status last verified
- Jan 2021
- First submitted
- 5 Nov 2013
- Last updated
- 27 Jan 2021
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Jan 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Asthma and Allergy Screening AA2000 (Cross Sectional)
- ClinicalTrials.gov ID
- NCT04727112
- Acronym / sponsor ID
- AA2000 / asthma and allergy screening
- Conditions
- Asthma
- Keywords
- asthma, airway hyperresponsiveness, asthma management
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 493 participants (actual)
- Lead sponsor
- Bispebjerg HospitalUniversity, hospital or other
- Study start
- Jan 2000
- Primary completion
- Jan 2003 (actual)
- Study completion
- Jan 2004 (actual)
- First posted
- 27 Jan 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Asthma screening of 493 asthma patients
Detailed description
Questionnaire, and testing
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| asthma and rhinitis | – | Drug: Usual care versus primary careScreening of patients with upper and lower airway symptoms |
| asthma and rhintis follow-up | – | Drug: Usual care versus primary caresame Group as screened in 2000, was followed up three years later |
Who may qualify
- Ages
- 15 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Population based asthma study
Key inclusion criteria (0 listed)
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Usual care versus primary careAlso: RCT study, usuar care in specialist setting (GINA and ARIA)RCT study | Drug | asthma and rhinitis, asthma and rhintis follow-up |
Primary outcome
ACQ
Time frame: 2004
Questionnaire based
AQLQ
Time frame: 2004
Questionnaire based
1 secondary outcome
FEV1
Time frame: 2004
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jan 2021.
Related trials for Asthma
RecruitingPhase 3
Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-063.
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Enrolling by invitationObservational study
Investigating Novel Strategies in Pediatric Immune Responses and Microbiome Environment: Comprehensive Lung Disease Investigation in Children.
Lung Diseases
Recruiting
Effects of Tele-rehabilitation-Guided Qigong on Children and Adolescents With Asthma
Asthma Childhood
RecruitingPhase 3
Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Vibeke Backer, MD principal investigator
Bispebjerg Hospital
Questions about this trial
What is this clinical trial studying?
An observational study of Asthma, run by Bispebjerg Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
ACQ (time frame: 2004). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2021.